Sudden cardiac death after acute ST elevation myocardial infarction: insight from a developing country

Abstract

SCD following STEMI accounts for about half of the total deaths. It involves younger population and most of these occur within the first month. This data has relevance in prioritising healthcare strategies in India.

Sudden cardiac death early after ST elevation myocardial infarction with and without severe left ventricular dysfunction

“…The methodology and patient characteristics have been previously described. 1 Briefly, patients admitted with acute STEMI were entered into a predesigned data base and follow up data was collected over a 3 year period. Deaths were classified as cardiovascular deaths (CVDs), non-cardiovascular or unclassifiable.…”

“…1 1. CVD: Deaths related to heart failure, ischemia, recurrent infarction, arrhythmic and non-arrhythmic sudden deaths, and cerebrovascular accidents.…”

“…It has been observed that there is a clustering of SCD cases in the early post MI period and we found in an earlier study that a significant proportion of SCD occur in the first month following ST elevation myocardial infarction (STEMI) event. 1 This report is designed to compare the temporal patterns and predictors of sudden death amongst the STEMI patients with and without severe LV dysfunction.…”

Role of omega-3 ethyl ester concentrate in reducing sudden cardiac death following myocardial infarction and in management of hypertriglyceridemia: An Indian consensus statement

“…It is projected that by the end of this decade, 60% of the world's heart disease cases will occur in India. 2 However, the proportion of cardiovascular deaths that are SCD events and the risk factor profile of the individuals at risk for SCD in India remain largely unknown. 3 In an Indian study the SCDs contribute about 10% of the total mortality and SCD post ST elevation myocardial infarction (MI) constitutes for about half of total deaths.…”

“…SCD involves younger population and most of these deaths occur within the first year, particularly in the first month. 2,3 Of the various pharmacological treatment modalities available, only b-blockers and amiodarone have been shown to be of some benefit in reducing SCD following MI. Implantable cardioverter-defibrillator (ICD) has emerged as the most successful therapeutic option, but it has its own limitations of cost and availability, precluding its wide application.…”